Physician profile
Leah K Ehle
NPI 1407086036
$418,085.23
in general payments reported to CMS, 2019-2025
5 companies · $33.32 in 2025
The $33.32 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82K · 2022: $160K · 2023: $126K · 2024: $50K · 2025: $33.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $121K · Travel and Lodging: $49K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,929 · Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $120,956.00 |
| Travel and Lodging | $48,857.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,928.99 |
| Food and Beverage | $577.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $417,337.94 | 2021-2024 | Sandostatin, Piqray, Kisqali |
| Janssen Biotech, INC. | $421.08 | 2024 | Rybrevant |
| Abbvie INC. | $156.48 | 2023-2025 | |
| Celgene Corporation | $123.25 | 2021 | |
| Glaxosmithkline, LLC. | $46.48 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Ehle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.